BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24716831)

  • 1. In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients.
    Lucarelli E; Bellotti C; Mantelli M; Avanzini MA; Maccario R; Novara F; Arrigo G; Zuffardi O; Zuntini M; Pandolfi M; Sangiorgi L; Lisini D; Donati D; Duchi S
    J Transl Med; 2014 Apr; 12():95. PubMed ID: 24716831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
    Bernardo ME; Zaffaroni N; Novara F; Cometa AM; Avanzini MA; Moretta A; Montagna D; Maccario R; Villa R; Daidone MG; Zuffardi O; Locatelli F
    Cancer Res; 2007 Oct; 67(19):9142-9. PubMed ID: 17909019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells.
    Redaelli S; Bentivegna A; Foudah D; Miloso M; Redondo J; Riva G; Baronchelli S; Dalprà L; Tredici G
    Stem Cell Res Ther; 2012 Nov; 3(6):47. PubMed ID: 23168092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].
    Huang K; Zhou DH; Huang SL; Liang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1049-53. PubMed ID: 16403278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.
    Brune JC; Tormin A; Johansson MC; Rissler P; Brosjö O; Löfvenberg R; von Steyern FV; Mertens F; Rydholm A; Scheding S
    Int J Cancer; 2011 Jul; 129(2):319-30. PubMed ID: 20878957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.
    Conforti A; Starc N; Biagini S; Tomao L; Pitisci A; Algeri M; Sirleto P; Novelli A; Grisendi G; Candini O; Carella C; Dominici M; Locatelli F; Bernardo ME
    Oncotarget; 2016 Nov; 7(47):77416-77429. PubMed ID: 27764806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
    Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow.
    Choumerianou DM; Dimitriou H; Perdikogianni C; Martimianaki G; Riminucci M; Kalmanti M
    Cell Prolif; 2008 Dec; 41(6):909-922. PubMed ID: 19040569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
    Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F
    Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.
    El Beaino M; Liu J; Wasylishen AR; Pourebrahim R; Migut A; Bessellieu BJ; Huang K; Lin PP
    BMC Cancer; 2020 Jan; 20(1):3. PubMed ID: 31898537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro.
    Yang YK; Ogando CR; Wang See C; Chang TY; Barabino GA
    Stem Cell Res Ther; 2018 May; 9(1):131. PubMed ID: 29751774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients.
    Ferrero I; Mazzini L; Rustichelli D; Gunetti M; Mareschi K; Testa L; Nasuelli N; Oggioni GD; Fagioli F
    Cell Transplant; 2008; 17(3):255-66. PubMed ID: 18522229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
    Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
    Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
    Mareschi K; Ferrero I; Rustichelli D; Aschero S; Gammaitoni L; Aglietta M; Madon E; Fagioli F
    J Cell Biochem; 2006 Mar; 97(4):744-54. PubMed ID: 16229018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bone marrow-derived mesenchymal stem cell quality from patients with congenital pseudoarthrosis of the tibia.
    Dilogo IH; Mujadid F; Nurhayati RW; Kurniawan A
    J Orthop Surg Res; 2018 Oct; 13(1):266. PubMed ID: 30352605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow.
    Kundrotas G; Gasperskaja E; Slapsyte G; Gudleviciene Z; Krasko J; Stumbryte A; Liudkeviciene R
    Oncotarget; 2016 Mar; 7(10):10788-802. PubMed ID: 26910916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.
    Le Nail LR; Brennan M; Rosset P; Deschaseaux F; Piloquet P; Pichon O; Le Caignec C; Crenn V; Layrolle P; Hérault O; De Pinieux G; Trichet V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.